<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>It is still a matter of debate whether patients who develop islet-cell antibody positive autoimmune <z:mp ids='MP_0002055'>diabetes</z:mp> during adulthood represent slowly evolving Type 1 (insulin-dependent) <z:hpo ids='HP_0000819'>diabetes mellitus</z:hpo> or a separate subgroup of Type 2 (non-insulin-dependent) <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
<SENT sid="1" pm="."><plain>To address this question, we measured C-<z:chebi fb="7" ids="16670">peptide</z:chebi> response to a test meal, and energy metabolism in the basal state and during a euglycaemic, hyperinsulinaemic clamp in (1) 29 patients with Type 2 <z:mp ids='MP_0002055'>diabetes</z:mp>; (2) 10 patients with autoimmune <z:mp ids='MP_0002055'>diabetes</z:mp> developing after the age of 40 years; (3) 11 patients with Type 1 <z:mp ids='MP_0002055'>diabetes</z:mp> and (4) 15 non-diabetic control subjects </plain></SENT>
<SENT sid="2" pm="."><plain>While C-<z:chebi fb="7" ids="16670">peptide</z:chebi> response to a test meal was lacking in Type 1 <z:mp ids='MP_0002055'>diabetes</z:mp> and nearly <z:mpath ids='MPATH_458'>normal</z:mpath> in Type 2 <z:mp ids='MP_0002055'>diabetes</z:mp>, the C-<z:chebi fb="7" ids="16670">peptide</z:chebi> response in autoimmune <z:mp ids='MP_0002055'>diabetes</z:mp> was markedly reduced </plain></SENT>
<SENT sid="3" pm="."><plain>Patients with Type 2 <z:mp ids='MP_0002055'>diabetes</z:mp>, autoimmune <z:mp ids='MP_0002055'>diabetes</z:mp> and Type 1 <z:mp ids='MP_0002055'>diabetes</z:mp> showed a 47%, 45% and 42%, respectively, reduction in the rate of non-oxidative <z:chebi fb="105" ids="17234">glucose</z:chebi> metabolism compared with control subjects (p less than 0.05-0.01) </plain></SENT>
<SENT sid="4" pm="."><plain>Similarly, patients with Type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> (+52%), autoimmune <z:mp ids='MP_0002055'>diabetes</z:mp> (+27%) and Type 1 <z:mp ids='MP_0002055'>diabetes</z:mp> (+33%) presented with an enhanced basal rate of hepatic <z:chebi fb="105" ids="17234">glucose</z:chebi> production, which was less suppressed by insulin compared with healthy control subjects (p less than 0.01) </plain></SENT>
<SENT sid="5" pm="."><plain>However, patients with autoimmune <z:mp ids='MP_0002055'>diabetes</z:mp> derived more energy from oxidation of <z:chebi fb="105" ids="17234">glucose</z:chebi> and proteins and less energy from oxidation of <z:chebi fb="23" ids="18059">lipids</z:chebi> than patients with either Type 1 or Type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> (p less than 0.05-0.01) </plain></SENT>
<SENT sid="6" pm="."><plain>In conclusion, patients who develop autoimmune <z:mp ids='MP_0002055'>diabetes</z:mp> during adulthood share the defects in hepatic <z:chebi fb="105" ids="17234">glucose</z:chebi> production and in non-oxidative <z:chebi fb="105" ids="17234">glucose</z:chebi> metabolism with both Type 1 and Type 2 <z:mp ids='MP_0002055'>diabetes</z:mp>.(ABSTRACT TRUNCATED AT 250 WORDS) </plain></SENT>
</text></document>